Aberrant proplatelet formation in chronic myeloproliferative neoplasms

被引:15
|
作者
Muth, Michaela [1 ]
Buesche, Guntram [1 ]
Bock, Oliver [1 ]
Hussein, Kais [1 ]
Kreipe, Hans [1 ]
机构
[1] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany
关键词
Proplatelets; Primary myelofibrosis; Pseudopodia; Megakaryocytes; Fibrosing and non-fibrosing MPN; BONE-MARROW; PLATELETS; CELLS; MEGAKARYOPOIESIS; MEGAKARYOCYTES; MYELOFIBROSIS; ANAGRELIDE;
D O I
10.1016/j.leukres.2010.03.040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Proplatelets represent pseudopodia of megakaryocytes which extend into bone marrow sinuses to release platelets. Proplatelets were visualized by immunohistochemical and confocal microscopy. In trephines from essential thrombocythaemia (ET, n = 10), fibrotic (n = 10) and pre-fibrotic (n = 10) primary myelofibrosis (PMF) there was a significant increase of proplatelet density compared with normal bone marrow samples (n = 10; p < 0.001). Manifest fibrosis exhibited the highest density and volume ratio with significant differences to non-fibrotic PMF (p < 0.001) and ET (p < 0.001). This study demonstrates that besides megakaryocytic proliferation extensive pseudopodial proplatelet formation provides a hallmark of MPN. Fibrosing differ from non-fibrosing MPN by density and size of aberrant proplatelets. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1424 / 1429
页数:6
相关论文
共 50 条
  • [1] Proplatelet production and stromal fibrosis in myeloproliferative neoplasms
    Wilkins, Bridget S.
    [J]. LEUKEMIA RESEARCH, 2010, 34 (11) : 1417 - 1419
  • [2] Study of Megakaryopoiesis and Proplatelet Formation In Myeloproliferative Disorders
    Badalucco, Stefania
    Pugliano, Maria Teresa
    Rosti, Vittorio
    Cattaneo, Marco
    Barosi, Giovanni
    Balduini, Alessandra
    [J]. BLOOD, 2010, 116 (21) : 1268 - 1268
  • [3] Study of megakaryopoiesis and proplatelet formation in myeloproliferative disorders
    Badalucco, S.
    Pugliano, M.
    Rosti, V
    Cattaneo, M.
    Barosi, G.
    Balduini, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 71 - 72
  • [4] Chronic myeloproliferative Neoplasms
    Griesshammer, M.
    Doehner, K.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (06) : 243 - 246
  • [5] Aberrant signal transduction pathways in myeloproliferative neoplasms
    Kota, J.
    Caceres, N.
    Constantinescu, S. N.
    [J]. LEUKEMIA, 2008, 22 (10) : 1828 - 1840
  • [6] Aberrant signal transduction pathways in myeloproliferative neoplasms
    J Kota
    N Caceres
    S N Constantinescu
    [J]. Leukemia, 2008, 22 : 1828 - 1840
  • [7] Classification of myeloproliferative neoplasms and chronic myeloproliferative disorders
    Kreipe, Hans H.
    [J]. ONKOLOGE, 2019, 25 (11): : 957 - 970
  • [8] Familial Chronic Myeloproliferative Neoplasms
    Alati, Caterina
    Martino, Bruno
    Marino, Antonio
    Ronco, Francesca
    Priolo, Manuela
    Nobile, Francesco
    [J]. BLOOD, 2010, 116 (21) : 1269 - 1269
  • [9] Chronic myeloproliferative neoplasms in the elderly
    Maffioli, Margherita
    Orlandi, Ester
    Passamonti, Francesco
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 58 : 33 - 42
  • [10] Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms
    Markovic, Dragana C.
    Maslovaric, Irina S.
    Kovacic, Marijana
    Vignjevic Petrinovic, Sanja
    Ilic, Vesna Lj.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)